- Datum23.06.2025
- Uhrzeit08:00 - 09:00 Uhr
- Veranstalter
XTB
Altan Cantürk
Moderator
NanoVibronix Inc. Aktie
Verkaufen
Kaufen
NanoVibronix Inc. Chart
NanoVibronix Inc. Realtime-Kurs
| Handelsplatz | Kurs | +/- (%) | +/- (abs) | Vortag | Zeit | Aktionen |
|---|---|---|---|---|---|---|
| L&S | VK | |||||
| Tradegate | VK | |||||
| Baader | VK |
Passende Produkte
| WKN | Long/Short | KO | Hebel | Laufzeit | Bid | Ask |
|---|
Keine Ergebnisse gefunden
Wertentwicklung (Nasdaq)
-3,61 %
Intraday
-9,80 %
1 Woche
-22,03 %
1 Monat
-85,82 %
Seit Jahresbeginn
-88,62 %
1 Jahr
-99,32 %
3 Jahre
-99,81 %
5 Jahre
Passender Service zu NanoVibronix Inc.
Webinar zu NanoVibronix Inc.
Kursinformationen (Nasdaq)
- Tagestief / Hoch ($)-
- 52W-Tief / Hoch ($)0,667-16,250
- Jahrestief / Hoch ($)0,667-16,250
- Schlusskurs (Vortag)
- Eröffnungskurs
- Volumen Intraday
Wichtigste Eigenschaften
Dividenden von NanoVibronix Inc.
Keine Dividenden verfügbar
Termine von NanoVibronix Inc.
Keine aktuellen Termine
Beschreibung
NanoVibronix Inc manufactures noninvasive biological response-activating devices that target biofilm prevention, pain therapy, and wound healing and can be administered at home, without the assistance of medical professionals. Its primary products are UroShield; PainShield; and WoundShield. Each of its UroShield, PainShield, and WoundShield products employs a small, disposable transducer that transmits low frequency, low intensity ultrasound acoustic waves that seek to repair and regenerate tissue, musculoskeletal and vascular structures, and decrease biofilm formation on urinary catheters and associated urinary tract infections. The company derives revenues from selling its products directly to patients as well as through distributor agreements.
